Golden Arrow Merger Corp.
Status: Deal Closed
U=S+W/3
W=S@11.50
| IPO Proceeds, $M | $287.50M |
|---|---|
| IPO Date | Mar 17, 2021 |
| CEO | Timothy Babich |
| Left Lead | BTIG |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 + 9 + 9 |
| IPO Sector |
Healthcare
Healthcare or healthcare-related infrastructure industries in the United States and other developed countries |
| IPO Geography | US/Canada |
| Target Company | Bolt Threads |
| Deal Announced | Oct 4, 2023 |
| Deal Size, $M | $346.10M |
| Deal Sector | Consumer |
| Deal Geography | US/Canada |
| SEC Filings | www.sec.gov |
| Approval Vote | Aug 9, 2024 |
| Amendment Vote | Dec 12, 2023 |
| Closing Date | Aug 13, 2024 |
Formerly GAMC
BSLK
BSLKW
| Price | $0.63 |
|---|---|
| Last closing price | $0.71 |
| H/L, today | $0.62 / $0.66 |
| Volume, today | 495,661 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Golden Arrow Merger Corp.:
- Structure and cap table
- 8 directors & officers
- 30 filings and events
- 2 underwriters
- 1 deal advisors
- 2 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Timothy Babich | 44 | Chief Executive Officer and Chief Financial Officer |
| Jacob Doft | 51 | Chairman of the Board |
| Lance Hirt | 53 | Director |
| Andrew Rechtschaffen | 43 | Director |
| Brett Barth | 49 | Director |
| Lloyd Dean | 70 | Director |
| Steven Klosk | 63 | Director |
| Jack Hidary | 52 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| BTIG | BR | 23,750,000 | units |
| I-Bankers Securities | 1,250,000 | ||
| 25,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee |
3.50 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.